Company Valuation: Docebo Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,199 1,088 1,469 1,354 639 514 - -
Change - -50.53% 35.05% -7.82% -52.82% -19.56% - -
Enterprise Value (EV) 1 1,983 871.5 1,397 1,262 564.9 557 502 380
Change - -56.06% 60.31% -9.69% -55.22% -1.4% -9.88% -24.31%
P/E -164x 157x 606x 118x 17.4x 21.8x 13.2x 13.2x
PBR - 5.66x 29x 23.5x 8.63x 24.9x 8.98x 4.92x
PEG - -1x -9.8x 0x 0x -0.8x 0.2x -34.45x
Capitalization / Revenue 21.1x 7.61x 8.12x 6.24x 2.63x 1.87x 1.71x 1.53x
EV / Revenue 19x 6.1x 7.73x 5.82x 2.33x 2.03x 1.67x 1.13x
EV / EBITDA -249x 676x 85.8x 37.5x 12.9x 10.1x 7.57x 4.78x
EV / EBIT -162x 208x -377x 59.3x 24.3x 17.6x 9.72x 5.93x
EV / FCF -451x 722x 91.1x 45.1x 20.8x 11.7x 9.08x -
FCF Yield -0.22% 0.14% 1.1% 2.22% 4.81% 8.57% 11% -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.41 0.21 0.08 0.38 1.28 0.946 1.566 1.56
Distribution rate - - - - - - - -
Net sales 1 104.2 142.9 180.8 216.9 242.7 274.6 301.1 334.9
EBITDA 1 -7.969 1.289 16.28 33.62 43.89 55.41 66.28 79.55
EBIT 1 -12.25 4.185 -3.71 21.29 23.24 31.65 51.63 64.1
Net income 1 -13.6 7.018 2.84 26.74 37.51 26.4 43.74 45.2
Net Debt 1 -215.3 -216.3 -71.95 -92.54 -74.04 43.04 -12.02 -134
Reference price 2 67.06 33.06 48.45 44.80 22.24 20.64 20.64 20.64
Nbr of stocks (in thousands) 32,784 32,906 30,319 30,228 28,735 24,899 - -
Announcement Date 3/10/22 3/9/23 2/23/24 2/28/25 2/27/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
23.66x8.73x14.24x0.86% 3,451B
91.04x36.73x61.23x-.--% 295B
484.04x20.87x83.79x-.--% 95.39B
70.97x14.93x31.47x-.--% 93.64B
144.06x8.46x21.6x-.--% 74.44B
35.52x1.87x14.62x-.--% 65.38B
118.38x5.19x25.41x-.--% 45.42B
20.14x3.78x10.43x1.4% 30.53B
93.27x4.83x23.25x-.--% 29.95B
Average 120.12x 11.71x 31.78x 0.25% 464.51B
Weighted average by Cap. 43.81x 10.90x 19.82x 0.72%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA